http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102019106270-B4
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5846ed1722d0bb1186befbfb2b991232 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-00781 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007 |
| filingDate | 2019-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0cd5a9d764b8cbdf35e824146c88e2e6 |
| publicationDate | 2021-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | DE-102019106270-B4 |
| titleOfInvention | Ophthalmic implant |
| abstract | Ophthalmic implant (11) for the microinvasive treatment of glaucoma in a human or animal patient, with a base body (12) which has a length (L) between a fluid pipeline (13) running linearly along a longitudinal axis (A) of the implant (11) 0.4 mm and 4.0 mm, the fluid conduit (13) having at least one first opening (14a) at a first end (13a) which is to be arranged in an anterior chamber (4) of a patient's eye, and at a second end (13b) has at least one second opening (14b) which is to be arranged in a vein (9) of the patient's eye in order to fluidically connect the anterior chamber (4) directly to the vein (9) in the implanted state, characterized in that the implant (11) has a refillable drug delivery system (19). |
| priorityDate | 2019-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 18.